NEWTON, Mass. (PRWEB) March 31, 2016
Hospital IQ today announced that Michael J. Zinner, M.D., CEO and Executive Medical Director of the Miami Cancer Institute has been elected to its board of directors.
Dr. Zinner brings more than four decades of clinical and executive leadership experience. Prior to his role at the Miami Cancer Institute, a new collaboration between Baptist Health South Florida and Memorial Sloan Kettering Cancer Center, he was the Surgeon-in-Chief at Brigham and Women’s Hospital (BWH), the Co-founder and Co-director of the Gastrointestinal Cancer Center at the Dana Farber Cancer Institute and the Founder of Harvard Medical School’s Center for Surgery and Public Health.
“I am thrilled that Dr. Zinner has accepted this appointment. His understanding of the operational challenges that hospitals face combined with his intimate knowledge of our solution as a customer at BWH provides him with a unique set of capabilities that will help us improve the cost and quality of healthcare delivery,” said Rich Krueger, Hospital IQ’s CEO. “Having one of the leading figures in the industry with such an impeccable reputation join us is an honor and further validates our mission and technology.”
“We are delighted to have such an experienced hospital leader join our board,” said Jarret Fass, a Hospital IQ board member. “I am confident that Dr. Zinner will make many important contributions to the company.”
“I have seen first-hand the benefit of Hospital IQ’s platform as a customer at BWH and am honored to be joining their board,” said Dr. Zinner. “The future of healthcare requires the sophisticated predictive tools that Hospital IQ makes accessible. I look forward to contributing to Hospital IQ’s continued success.”
Dr. Zinner’s distinguished career includes serving on the Board of Directors of Partners HealthCare System and the Sisters of Mercy Health System. He was also the Vice Chairman of the Department of Surgery and Co-director of the Gastrointestinal Service at Johns Hopkins Hospital, the Chairman of the Department of Surgery at UCLA Medical School and Medical Center and the Clinical Director at the Dana-Farber/Brigham and Women’s Cancer Center. Dr. Zinner has authored more than 230 academic papers and is a member of the editorial boards of Annals of Surgery, Journal of Gastrointestinal Surgery and the Journal of the American College of Surgeons.
About Hospital IQ:
Hospital IQ is the leading predictive analytics platform improving operational efficiency in hospitals through smarter data-driven decision making. The company works with a number of leading institutions including Brigham and Women’s Hospital to systematically improve utilization and throughput across a hospital by aligning staff, schedules and capacity with patient flow. Hospital IQ’s automated reporting, modeling and prediction tools allow executives to proactively plan for and anticipate census variability. The company was founded by a veteran team of operations management and software engineers driven by a mission to improve hospital efficiency. The company is headquartered in Newton, Massachusetts. For more information, visit http://www.hospiq.com.